Pharmaceuticals

Toxicology Drug Screening Market Analysis Covering Growth Drivers And Future Outlook

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Toxicology Drug Screening Market Compare Between 2026 And 2030?

The toxicology drug screening market has seen substantial growth in recent years. This market is anticipated to expand from $21.44 billion in 2025 to $23.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. The historical growth of this market can be attributed to factors such as dependence on manual toxicology testing methods, limited automation in laboratories, the increasing prevalence of substance abuse monitoring, heightened regulatory oversight, and the adoption of conventional bioanalytical instrumentation.

The toxicology drug screening market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $33.48 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period is fueled by factors such as the creation of AI-driven predictive toxicology tools, the incorporation of genomics and transcriptomics into screening methods, the expansion of contract research organizations (cros), an increasing need for real-time drug monitoring systems, and the deployment of cloud-based, secure data management platforms. Significant trends for the forecast period encompass the increasing embrace of high-throughput screening technologies, the integration of lims and laboratory information systems, a heightened reliance on predictive and AI-powered toxicology platforms, the broadening of workplace drug screening programs, and an intensified focus on data security and compliance standards.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

What Leading Drivers Are Supporting The Toxicology Drug Screening Market Expansion?

The toxicology drug screening market is anticipated to expand due to the increasing incidence of drug abuse. Drug abuse refers to the detrimental or excessive consumption of drugs for reasons other than medical, adversely affecting an individual’s health and life. The growing occurrence of drug abuse stems from heightened stress and mental health issues, prompting numerous people to misuse substances as a coping mechanism. Toxicology drug screening proves beneficial in addressing drug abuse by facilitating the detection of drugs or their breakdown products within an individual’s system, thereby allowing for prompt identification, diagnosis, and oversight of substance misuse or potential overdose. For example, data released in August 2024 by the National Records of Scotland (NRS), a government department in Scotland, revealed that Scotland documented 1,172 drug misuse deaths in 2023, representing a 12% increase (121 additional deaths) from the figures in 2022. Consequently, the increasing prevalence of drug abuse serves as a key driver for the toxicology drug screening market.

Which Segments Define The Toxicology Drug Screening Market Segment Structure?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

Which Trends Are Impacting The Progress Of The Toxicology Drug Screening Market?

Leading enterprises within the toxicology drug screening market are prioritizing the introduction of groundbreaking solutions, such as the 3D liver microphysiological system, which facilitates the cultivation of highly biomimetic human liver microtissues exhibiting organized cellular structures and dynamic metabolic activity. This 3D liver microphysiological system (MPS) functions as an advanced in vitro platform, specifically engineered to mimic the physiological surroundings of the human liver with greater precision compared to conventional cell culture techniques, often involving the growth of various human liver cell types. For example, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences firm specializing in organ-on-a-chip (OOC) technologies, unveiled the PhysioMimix DILI assay kit. This comprehensive laboratory kit is designed for the in vitro assessment of human drug-induced liver injury and incorporates a thoroughly characterized 3D liver microphysiological system (MPS) capable of recreating metabolically active, highly functional human liver tissue along with Kupffer cells. Furthermore, it allows for easy integration of organ-on-a-chip technology through a plug-and-play format, thereby streamlining its deployment and accelerating the adoption process.

Who Are The Established Players Within The Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Get The Full Toxicology Drug Screening Market Report:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Region Dominates The Toxicology Drug Screening Market By Market Share?

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Toxicology Drug Screening Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795